Anika Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -38.9% | -38.9% | -30.5% |
| FY2024 | -36.6% | -36.6% | -27.8% |
| FY2025 | -7.6% | -7.6% | -5.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -38.9% | -38.9% | -30.5% |
| FY2024 | -36.6% | -36.6% | -27.8% |
| FY2025 | -7.6% | -7.6% | -5.7% |